Frequency characteristics of blood pressure oscillations evoked by sympathetic transmitters, noradrenaline and adenosine triphosphate
Mean arterial pressure (MAP) was recorded beat-to-beat in chronically instrumented, conscious, unrestrained rats under control conditions and after pharmacological inhibition of vascular sympathetic influences by means of: (1) ganglion blockade with chlorisondamine; (2) α-adrenoceptor antagonist phe...
Gespeichert in:
Veröffentlicht in: | Journal of the autonomic nervous system 1999-07, Vol.77 (1), p.13-20 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 20 |
---|---|
container_issue | 1 |
container_start_page | 13 |
container_title | Journal of the autonomic nervous system |
container_volume | 77 |
creator | Golubinskaya, Veronika O Tarasova, Olga S Borovik, Anatoly S Rodionov, Ivan M |
description | Mean arterial pressure (MAP) was recorded beat-to-beat in chronically instrumented, conscious, unrestrained rats under control conditions and after pharmacological inhibition of vascular sympathetic influences by means of: (1) ganglion blockade with chlorisondamine; (2) α-adrenoceptor antagonist phentolamine; (3) P2 receptor blockade with pyridoxalphosphate-6-azophenyl-2′,4′-disulphonic acid (PPADS). Angiotensin II was continuously infused to prevent drastic MAP decrease during chlorisondamine and phentolamine administration. Overall MAP variability increased after ganglion blockade and combined blockade of adreno- and purinoceptors. It increased also after inhibition of purinergic influences, but was not significantly changed after vascular adrenergic blockade. Spectral analysis of spontaneous MAP fluctuations in intact rats revealed a peak centered at 0.4–0.5 Hz. Ganglion blockade suppressed MAP fluctuations with frequencies from 0.1 to 0.8 Hz. After blockade of α-adrenoceptors, MAP spectral density was suppressed only within the 0.1–0.45-Hz band, but increased in the 0.45–0.8-Hz band. In the latter case, sympathetically-induced peak of MAP spectrum was centered on 0.6 Hz, being evoked, presumably, by adenosine triphosphate (ATP). Blockade of P2 receptors by PPADS enhanced MAP fluctuations in the 0.1–0.45-Hz frequency band, i.e. the noradrenaline-induced peak was centered on 0.2 Hz. No peaks were observed in the 0.1–0.8-Hz frequency band during combined blockade of adreno- and purinoceptors. The present study supports the concept that sympathetic purinergic co-transmission is essential for stabilization of MAP level. MAP fluctuations evoked by noradrenaline and ATP can be distinguished by their frequency characteristics. |
doi_str_mv | 10.1016/S0165-1838(99)00025-9 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70777586</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0165183899000259</els_id><sourcerecordid>70777586</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-cc7bd7ec430aaaffcf9bf526984c9c61fca82738d8bddb4c4fad3b4a8905e8ab3</originalsourceid><addsrcrecordid>eNqFkd9qFDEUh4Modlt9BCUXIgqOZnb-JLkqUlotFHpRvQ5nkhM2OjMZc7KFfYC-t9nuot55k0Pg-52T84WxV7X4WIu6_3RXjq6qVaPeaf1eCLHuKv2ErWol15VsZf-Urf4gJ-yU6IcQtRRaPWcntWh1K9tuxR6uEv7a4mx33G4ggc2YAuVgiUfPhzFGx5eERNuEPJIN4wg5xJk43sef6Piw47SbFsgbLCmeE8w0hVza0Ac-xwQu4QxjmJHD7Dg4nCPtbzmFZRNp2UDGF-yZh5Hw5bGese9Xl98uvlY3t1-uLz7fVLbRIlfWysFJtG0jAMB76_Xgu3WvVWu17WtvQa1lo5wanBta23pwzdCC0qJDBUNzxt4e-i4plq0pmymQxbLTjHFLRgopZaf6AnYH0KZIlNCbJYUJ0s7Uwuz9m0f_Zi_XaG0e_Rtdcq-PA7bDhO6f1EF4Ad4cASALoy-6bKC_nO4apWXBzg8YFhv3AZMp6ssvoQsJbTYuhv-85DcJB6gP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70777586</pqid></control><display><type>article</type><title>Frequency characteristics of blood pressure oscillations evoked by sympathetic transmitters, noradrenaline and adenosine triphosphate</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Golubinskaya, Veronika O ; Tarasova, Olga S ; Borovik, Anatoly S ; Rodionov, Ivan M</creator><creatorcontrib>Golubinskaya, Veronika O ; Tarasova, Olga S ; Borovik, Anatoly S ; Rodionov, Ivan M</creatorcontrib><description>Mean arterial pressure (MAP) was recorded beat-to-beat in chronically instrumented, conscious, unrestrained rats under control conditions and after pharmacological inhibition of vascular sympathetic influences by means of: (1) ganglion blockade with chlorisondamine; (2) α-adrenoceptor antagonist phentolamine; (3) P2 receptor blockade with pyridoxalphosphate-6-azophenyl-2′,4′-disulphonic acid (PPADS). Angiotensin II was continuously infused to prevent drastic MAP decrease during chlorisondamine and phentolamine administration. Overall MAP variability increased after ganglion blockade and combined blockade of adreno- and purinoceptors. It increased also after inhibition of purinergic influences, but was not significantly changed after vascular adrenergic blockade. Spectral analysis of spontaneous MAP fluctuations in intact rats revealed a peak centered at 0.4–0.5 Hz. Ganglion blockade suppressed MAP fluctuations with frequencies from 0.1 to 0.8 Hz. After blockade of α-adrenoceptors, MAP spectral density was suppressed only within the 0.1–0.45-Hz band, but increased in the 0.45–0.8-Hz band. In the latter case, sympathetically-induced peak of MAP spectrum was centered on 0.6 Hz, being evoked, presumably, by adenosine triphosphate (ATP). Blockade of P2 receptors by PPADS enhanced MAP fluctuations in the 0.1–0.45-Hz frequency band, i.e. the noradrenaline-induced peak was centered on 0.2 Hz. No peaks were observed in the 0.1–0.8-Hz frequency band during combined blockade of adreno- and purinoceptors. The present study supports the concept that sympathetic purinergic co-transmission is essential for stabilization of MAP level. MAP fluctuations evoked by noradrenaline and ATP can be distinguished by their frequency characteristics.</description><identifier>ISSN: 0165-1838</identifier><identifier>EISSN: 1872-7476</identifier><identifier>DOI: 10.1016/S0165-1838(99)00025-9</identifier><identifier>PMID: 10494745</identifier><identifier>CODEN: JASYDS</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Adenosine Triphosphate - pharmacology ; Animals ; ATP ; Blood Pressure - drug effects ; Blood Pressure - physiology ; Blood pressure variability ; Chlorisondamine - pharmacology ; Consciousness ; Fourier Analysis ; Ganglionic Blockers - pharmacology ; Male ; Noradrenaline ; Norepinephrine - pharmacology ; Periodicity ; Phentolamine - pharmacology ; Platelet Aggregation Inhibitors - pharmacology ; PPADS ; Pyridoxal Phosphate - analogs & derivatives ; Pyridoxal Phosphate - pharmacology ; Rat ; Rats ; Receptors, Purinergic - physiology ; Sympathetic nervous system ; Sympathetic Nervous System - chemistry ; Sympathetic Nervous System - drug effects ; Sympathetic Nervous System - physiology ; Sympatholytics - pharmacology ; Sympathomimetics - pharmacology</subject><ispartof>Journal of the autonomic nervous system, 1999-07, Vol.77 (1), p.13-20</ispartof><rights>1999 Elsevier Science B.V.</rights><rights>1999 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-cc7bd7ec430aaaffcf9bf526984c9c61fca82738d8bddb4c4fad3b4a8905e8ab3</citedby><cites>FETCH-LOGICAL-c390t-cc7bd7ec430aaaffcf9bf526984c9c61fca82738d8bddb4c4fad3b4a8905e8ab3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1953897$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10494745$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Golubinskaya, Veronika O</creatorcontrib><creatorcontrib>Tarasova, Olga S</creatorcontrib><creatorcontrib>Borovik, Anatoly S</creatorcontrib><creatorcontrib>Rodionov, Ivan M</creatorcontrib><title>Frequency characteristics of blood pressure oscillations evoked by sympathetic transmitters, noradrenaline and adenosine triphosphate</title><title>Journal of the autonomic nervous system</title><addtitle>J Auton Nerv Syst</addtitle><description>Mean arterial pressure (MAP) was recorded beat-to-beat in chronically instrumented, conscious, unrestrained rats under control conditions and after pharmacological inhibition of vascular sympathetic influences by means of: (1) ganglion blockade with chlorisondamine; (2) α-adrenoceptor antagonist phentolamine; (3) P2 receptor blockade with pyridoxalphosphate-6-azophenyl-2′,4′-disulphonic acid (PPADS). Angiotensin II was continuously infused to prevent drastic MAP decrease during chlorisondamine and phentolamine administration. Overall MAP variability increased after ganglion blockade and combined blockade of adreno- and purinoceptors. It increased also after inhibition of purinergic influences, but was not significantly changed after vascular adrenergic blockade. Spectral analysis of spontaneous MAP fluctuations in intact rats revealed a peak centered at 0.4–0.5 Hz. Ganglion blockade suppressed MAP fluctuations with frequencies from 0.1 to 0.8 Hz. After blockade of α-adrenoceptors, MAP spectral density was suppressed only within the 0.1–0.45-Hz band, but increased in the 0.45–0.8-Hz band. In the latter case, sympathetically-induced peak of MAP spectrum was centered on 0.6 Hz, being evoked, presumably, by adenosine triphosphate (ATP). Blockade of P2 receptors by PPADS enhanced MAP fluctuations in the 0.1–0.45-Hz frequency band, i.e. the noradrenaline-induced peak was centered on 0.2 Hz. No peaks were observed in the 0.1–0.8-Hz frequency band during combined blockade of adreno- and purinoceptors. The present study supports the concept that sympathetic purinergic co-transmission is essential for stabilization of MAP level. MAP fluctuations evoked by noradrenaline and ATP can be distinguished by their frequency characteristics.</description><subject>Adenosine Triphosphate - pharmacology</subject><subject>Animals</subject><subject>ATP</subject><subject>Blood Pressure - drug effects</subject><subject>Blood Pressure - physiology</subject><subject>Blood pressure variability</subject><subject>Chlorisondamine - pharmacology</subject><subject>Consciousness</subject><subject>Fourier Analysis</subject><subject>Ganglionic Blockers - pharmacology</subject><subject>Male</subject><subject>Noradrenaline</subject><subject>Norepinephrine - pharmacology</subject><subject>Periodicity</subject><subject>Phentolamine - pharmacology</subject><subject>Platelet Aggregation Inhibitors - pharmacology</subject><subject>PPADS</subject><subject>Pyridoxal Phosphate - analogs & derivatives</subject><subject>Pyridoxal Phosphate - pharmacology</subject><subject>Rat</subject><subject>Rats</subject><subject>Receptors, Purinergic - physiology</subject><subject>Sympathetic nervous system</subject><subject>Sympathetic Nervous System - chemistry</subject><subject>Sympathetic Nervous System - drug effects</subject><subject>Sympathetic Nervous System - physiology</subject><subject>Sympatholytics - pharmacology</subject><subject>Sympathomimetics - pharmacology</subject><issn>0165-1838</issn><issn>1872-7476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkd9qFDEUh4Modlt9BCUXIgqOZnb-JLkqUlotFHpRvQ5nkhM2OjMZc7KFfYC-t9nuot55k0Pg-52T84WxV7X4WIu6_3RXjq6qVaPeaf1eCLHuKv2ErWol15VsZf-Urf4gJ-yU6IcQtRRaPWcntWh1K9tuxR6uEv7a4mx33G4ggc2YAuVgiUfPhzFGx5eERNuEPJIN4wg5xJk43sef6Piw47SbFsgbLCmeE8w0hVza0Ac-xwQu4QxjmJHD7Dg4nCPtbzmFZRNp2UDGF-yZh5Hw5bGese9Xl98uvlY3t1-uLz7fVLbRIlfWysFJtG0jAMB76_Xgu3WvVWu17WtvQa1lo5wanBta23pwzdCC0qJDBUNzxt4e-i4plq0pmymQxbLTjHFLRgopZaf6AnYH0KZIlNCbJYUJ0s7Uwuz9m0f_Zi_XaG0e_Rtdcq-PA7bDhO6f1EF4Ad4cASALoy-6bKC_nO4apWXBzg8YFhv3AZMp6ssvoQsJbTYuhv-85DcJB6gP</recordid><startdate>19990707</startdate><enddate>19990707</enddate><creator>Golubinskaya, Veronika O</creator><creator>Tarasova, Olga S</creator><creator>Borovik, Anatoly S</creator><creator>Rodionov, Ivan M</creator><general>Elsevier B.V</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19990707</creationdate><title>Frequency characteristics of blood pressure oscillations evoked by sympathetic transmitters, noradrenaline and adenosine triphosphate</title><author>Golubinskaya, Veronika O ; Tarasova, Olga S ; Borovik, Anatoly S ; Rodionov, Ivan M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-cc7bd7ec430aaaffcf9bf526984c9c61fca82738d8bddb4c4fad3b4a8905e8ab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adenosine Triphosphate - pharmacology</topic><topic>Animals</topic><topic>ATP</topic><topic>Blood Pressure - drug effects</topic><topic>Blood Pressure - physiology</topic><topic>Blood pressure variability</topic><topic>Chlorisondamine - pharmacology</topic><topic>Consciousness</topic><topic>Fourier Analysis</topic><topic>Ganglionic Blockers - pharmacology</topic><topic>Male</topic><topic>Noradrenaline</topic><topic>Norepinephrine - pharmacology</topic><topic>Periodicity</topic><topic>Phentolamine - pharmacology</topic><topic>Platelet Aggregation Inhibitors - pharmacology</topic><topic>PPADS</topic><topic>Pyridoxal Phosphate - analogs & derivatives</topic><topic>Pyridoxal Phosphate - pharmacology</topic><topic>Rat</topic><topic>Rats</topic><topic>Receptors, Purinergic - physiology</topic><topic>Sympathetic nervous system</topic><topic>Sympathetic Nervous System - chemistry</topic><topic>Sympathetic Nervous System - drug effects</topic><topic>Sympathetic Nervous System - physiology</topic><topic>Sympatholytics - pharmacology</topic><topic>Sympathomimetics - pharmacology</topic><toplevel>online_resources</toplevel><creatorcontrib>Golubinskaya, Veronika O</creatorcontrib><creatorcontrib>Tarasova, Olga S</creatorcontrib><creatorcontrib>Borovik, Anatoly S</creatorcontrib><creatorcontrib>Rodionov, Ivan M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the autonomic nervous system</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Golubinskaya, Veronika O</au><au>Tarasova, Olga S</au><au>Borovik, Anatoly S</au><au>Rodionov, Ivan M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Frequency characteristics of blood pressure oscillations evoked by sympathetic transmitters, noradrenaline and adenosine triphosphate</atitle><jtitle>Journal of the autonomic nervous system</jtitle><addtitle>J Auton Nerv Syst</addtitle><date>1999-07-07</date><risdate>1999</risdate><volume>77</volume><issue>1</issue><spage>13</spage><epage>20</epage><pages>13-20</pages><issn>0165-1838</issn><eissn>1872-7476</eissn><coden>JASYDS</coden><abstract>Mean arterial pressure (MAP) was recorded beat-to-beat in chronically instrumented, conscious, unrestrained rats under control conditions and after pharmacological inhibition of vascular sympathetic influences by means of: (1) ganglion blockade with chlorisondamine; (2) α-adrenoceptor antagonist phentolamine; (3) P2 receptor blockade with pyridoxalphosphate-6-azophenyl-2′,4′-disulphonic acid (PPADS). Angiotensin II was continuously infused to prevent drastic MAP decrease during chlorisondamine and phentolamine administration. Overall MAP variability increased after ganglion blockade and combined blockade of adreno- and purinoceptors. It increased also after inhibition of purinergic influences, but was not significantly changed after vascular adrenergic blockade. Spectral analysis of spontaneous MAP fluctuations in intact rats revealed a peak centered at 0.4–0.5 Hz. Ganglion blockade suppressed MAP fluctuations with frequencies from 0.1 to 0.8 Hz. After blockade of α-adrenoceptors, MAP spectral density was suppressed only within the 0.1–0.45-Hz band, but increased in the 0.45–0.8-Hz band. In the latter case, sympathetically-induced peak of MAP spectrum was centered on 0.6 Hz, being evoked, presumably, by adenosine triphosphate (ATP). Blockade of P2 receptors by PPADS enhanced MAP fluctuations in the 0.1–0.45-Hz frequency band, i.e. the noradrenaline-induced peak was centered on 0.2 Hz. No peaks were observed in the 0.1–0.8-Hz frequency band during combined blockade of adreno- and purinoceptors. The present study supports the concept that sympathetic purinergic co-transmission is essential for stabilization of MAP level. MAP fluctuations evoked by noradrenaline and ATP can be distinguished by their frequency characteristics.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>10494745</pmid><doi>10.1016/S0165-1838(99)00025-9</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0165-1838 |
ispartof | Journal of the autonomic nervous system, 1999-07, Vol.77 (1), p.13-20 |
issn | 0165-1838 1872-7476 |
language | eng |
recordid | cdi_proquest_miscellaneous_70777586 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Adenosine Triphosphate - pharmacology Animals ATP Blood Pressure - drug effects Blood Pressure - physiology Blood pressure variability Chlorisondamine - pharmacology Consciousness Fourier Analysis Ganglionic Blockers - pharmacology Male Noradrenaline Norepinephrine - pharmacology Periodicity Phentolamine - pharmacology Platelet Aggregation Inhibitors - pharmacology PPADS Pyridoxal Phosphate - analogs & derivatives Pyridoxal Phosphate - pharmacology Rat Rats Receptors, Purinergic - physiology Sympathetic nervous system Sympathetic Nervous System - chemistry Sympathetic Nervous System - drug effects Sympathetic Nervous System - physiology Sympatholytics - pharmacology Sympathomimetics - pharmacology |
title | Frequency characteristics of blood pressure oscillations evoked by sympathetic transmitters, noradrenaline and adenosine triphosphate |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T16%3A12%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Frequency%20characteristics%20of%20blood%20pressure%20oscillations%20evoked%20by%20sympathetic%20transmitters,%20noradrenaline%20and%20adenosine%20triphosphate&rft.jtitle=Journal%20of%20the%20autonomic%20nervous%20system&rft.au=Golubinskaya,%20Veronika%20O&rft.date=1999-07-07&rft.volume=77&rft.issue=1&rft.spage=13&rft.epage=20&rft.pages=13-20&rft.issn=0165-1838&rft.eissn=1872-7476&rft.coden=JASYDS&rft_id=info:doi/10.1016/S0165-1838(99)00025-9&rft_dat=%3Cproquest_cross%3E70777586%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70777586&rft_id=info:pmid/10494745&rft_els_id=S0165183899000259&rfr_iscdi=true |